Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action

The molecular mechanisms governing the pathogenesis of ACTH-secreting pituitary adenomas are still obscure. Furthermore, the pharmacological treatment of these tumors is limited. In this study, we report that bone morphogenetic protein-4 (BMP-4) is expressed in the corticotrophs of human normal aden...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Giacomini, Damiana Paula, Páez Pereda, Marcelo, Labeur, Marta Susana, Refojo, Damián, Gerez, Juan Atilio
Publicado: 2006
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v147_n1_p247_Giacomini
http://hdl.handle.net/20.500.12110/paper_00137227_v147_n1_p247_Giacomini
Aporte de:
id paper:paper_00137227_v147_n1_p247_Giacomini
record_format dspace
spelling paper:paper_00137227_v147_n1_p247_Giacomini2023-06-08T14:36:12Z Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action Giacomini, Damiana Paula Páez Pereda, Marcelo Labeur, Marta Susana Refojo, Damián Gerez, Juan Atilio bone morphogenetic protein 4 corticotropin noggin retinoic acid Smad4 protein adenohypophysis animal cell animal experiment animal model animal tissue article cancer inhibition carcinogenicity cell line cell proliferation comparative study controlled study corticotropin release Cushing disease disease course enzyme inhibition genetic transfection human human tissue mouse nonhuman priority journal protein expression signal transduction transcription initiation Adenoma Animals Bone Morphogenetic Proteins Cell Division Cell Line, Tumor Cushing Syndrome Humans Immunohistochemistry Mice Pituitary Gland Pituitary Neoplasms Reference Values Tretinoin The molecular mechanisms governing the pathogenesis of ACTH-secreting pituitary adenomas are still obscure. Furthermore, the pharmacological treatment of these tumors is limited. In this study, we report that bone morphogenetic protein-4 (BMP-4) is expressed in the corticotrophs of human normal adenohypophysis and its expression is reduced in corticotrophinomas obtained from Cushing's patients compared with the normal pituitary. BMP-4 treatment of AtT-20 mouse corticotrophinoma cells has an inhibitory effect on ACTH secretion and cell proliferation. AtT-20 cells stably transfected with a dominant-negative form of the BMP-4 signal cotransducer Smad-4 or the BMP-4 inhibitor noggin have increased tumorigenicity in nude mice, showing that BMP-4 has an inhibitory role on corticotroph tumorigenesis in vivo. Because the activation of the retinoic acid receptor has an inhibitory action on Cushing's disease progression, we analyzed the putative interaction of these two pathways. Indeed, retinoic acid induces both BMP-4 transcription and expression and its antiproliferative action is blocked in Smad-4dn- and noggin-transfected Att-20 cells that do not respond to BMP-4. Therefore, retinoic acid induces BMP-4, which participates in the antiproliferative effects of retinoic acid. This new mechanism is a potential target for therapeutic approaches for Cushing's disease. Copyright © 2006 by The Endocrine Society. Fil:Giacomini, D. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Páez-Pereda, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Labeur, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Refojo, D. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Gerez, J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2006 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v147_n1_p247_Giacomini http://hdl.handle.net/20.500.12110/paper_00137227_v147_n1_p247_Giacomini
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic bone morphogenetic protein 4
corticotropin
noggin
retinoic acid
Smad4 protein
adenohypophysis
animal cell
animal experiment
animal model
animal tissue
article
cancer inhibition
carcinogenicity
cell line
cell proliferation
comparative study
controlled study
corticotropin release
Cushing disease
disease course
enzyme inhibition
genetic transfection
human
human tissue
mouse
nonhuman
priority journal
protein expression
signal transduction
transcription initiation
Adenoma
Animals
Bone Morphogenetic Proteins
Cell Division
Cell Line, Tumor
Cushing Syndrome
Humans
Immunohistochemistry
Mice
Pituitary Gland
Pituitary Neoplasms
Reference Values
Tretinoin
spellingShingle bone morphogenetic protein 4
corticotropin
noggin
retinoic acid
Smad4 protein
adenohypophysis
animal cell
animal experiment
animal model
animal tissue
article
cancer inhibition
carcinogenicity
cell line
cell proliferation
comparative study
controlled study
corticotropin release
Cushing disease
disease course
enzyme inhibition
genetic transfection
human
human tissue
mouse
nonhuman
priority journal
protein expression
signal transduction
transcription initiation
Adenoma
Animals
Bone Morphogenetic Proteins
Cell Division
Cell Line, Tumor
Cushing Syndrome
Humans
Immunohistochemistry
Mice
Pituitary Gland
Pituitary Neoplasms
Reference Values
Tretinoin
Giacomini, Damiana Paula
Páez Pereda, Marcelo
Labeur, Marta Susana
Refojo, Damián
Gerez, Juan Atilio
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
topic_facet bone morphogenetic protein 4
corticotropin
noggin
retinoic acid
Smad4 protein
adenohypophysis
animal cell
animal experiment
animal model
animal tissue
article
cancer inhibition
carcinogenicity
cell line
cell proliferation
comparative study
controlled study
corticotropin release
Cushing disease
disease course
enzyme inhibition
genetic transfection
human
human tissue
mouse
nonhuman
priority journal
protein expression
signal transduction
transcription initiation
Adenoma
Animals
Bone Morphogenetic Proteins
Cell Division
Cell Line, Tumor
Cushing Syndrome
Humans
Immunohistochemistry
Mice
Pituitary Gland
Pituitary Neoplasms
Reference Values
Tretinoin
description The molecular mechanisms governing the pathogenesis of ACTH-secreting pituitary adenomas are still obscure. Furthermore, the pharmacological treatment of these tumors is limited. In this study, we report that bone morphogenetic protein-4 (BMP-4) is expressed in the corticotrophs of human normal adenohypophysis and its expression is reduced in corticotrophinomas obtained from Cushing's patients compared with the normal pituitary. BMP-4 treatment of AtT-20 mouse corticotrophinoma cells has an inhibitory effect on ACTH secretion and cell proliferation. AtT-20 cells stably transfected with a dominant-negative form of the BMP-4 signal cotransducer Smad-4 or the BMP-4 inhibitor noggin have increased tumorigenicity in nude mice, showing that BMP-4 has an inhibitory role on corticotroph tumorigenesis in vivo. Because the activation of the retinoic acid receptor has an inhibitory action on Cushing's disease progression, we analyzed the putative interaction of these two pathways. Indeed, retinoic acid induces both BMP-4 transcription and expression and its antiproliferative action is blocked in Smad-4dn- and noggin-transfected Att-20 cells that do not respond to BMP-4. Therefore, retinoic acid induces BMP-4, which participates in the antiproliferative effects of retinoic acid. This new mechanism is a potential target for therapeutic approaches for Cushing's disease. Copyright © 2006 by The Endocrine Society.
author Giacomini, Damiana Paula
Páez Pereda, Marcelo
Labeur, Marta Susana
Refojo, Damián
Gerez, Juan Atilio
author_facet Giacomini, Damiana Paula
Páez Pereda, Marcelo
Labeur, Marta Susana
Refojo, Damián
Gerez, Juan Atilio
author_sort Giacomini, Damiana Paula
title Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
title_short Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
title_full Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
title_fullStr Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
title_full_unstemmed Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action
title_sort bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action
publishDate 2006
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00137227_v147_n1_p247_Giacomini
http://hdl.handle.net/20.500.12110/paper_00137227_v147_n1_p247_Giacomini
work_keys_str_mv AT giacominidamianapaula bonemorphogeneticprotein4inhibitscorticotrophtumorcellsinvolvementintheretinoicacidinhibitoryaction
AT paezperedamarcelo bonemorphogeneticprotein4inhibitscorticotrophtumorcellsinvolvementintheretinoicacidinhibitoryaction
AT labeurmartasusana bonemorphogeneticprotein4inhibitscorticotrophtumorcellsinvolvementintheretinoicacidinhibitoryaction
AT refojodamian bonemorphogeneticprotein4inhibitscorticotrophtumorcellsinvolvementintheretinoicacidinhibitoryaction
AT gerezjuanatilio bonemorphogeneticprotein4inhibitscorticotrophtumorcellsinvolvementintheretinoicacidinhibitoryaction
_version_ 1768542299044708352